Nocturnal oxygen therapy as an option for early COVID-19 | Zendy

Chongxing Shen | Zendy; Xiaofeng Yue | Zendy; Jianwu Wang | Zendy; Chunmeng Shi | Zendy; Weibing Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nocturnal oxygen therapy as an option for early COVID-19

Author(s) -

Chongxing Shen,

Xiaofeng Yue,

Jianwu Wang,

Chunmeng Shi,

Weibing Li

Publication year - 2020

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2020.06.080

Subject(s) - oxygen therapy , covid-19 , quarantine , nocturnal , medicine , disease , antiviral therapy , coronavirus , intensive care medicine , virus , immunology , virology , infectious disease (medical specialty) , pathology , outbreak , chronic hepatitis

There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research